Dennis McNamara
University of Pittsburgh · University of Pittsburgh Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Dennis McNamara as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:38 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05180240 · Impact of CardiolRx on Myocardial Recovery in Patients With Acute MyocarditisCardiol Therapeutics Inc. · completed · Acute Myocarditis · study chair
- Ph4NCT05180773 · Impact of Bromocriptine on Clinical Outcomes for Peripartum CardiomyopathyDennis M. McNamara, MD, MS · recruiting · Peripartum Cardiomyopathy, Postpartum · principal investigator
- Ph2/Ph3NCT04615949 · Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk FactorsCardiol Therapeutics Inc. · terminated · COVID-19, Cardiovascular Diseases, Cardiovascular Risk Factor · study chair
- N/ANCT02305095 · Genomic Response Analysis of Heart Failure Therapy in African AmericansUniversity of Pittsburgh · completed · Heart Failure · principal investigator
- N/ANCT01085955 · Investigation in Pregnancy Associate CardiomyopathyUniversity of Pittsburgh · completed · Cardiomyopathy, Pregnancy · principal investigator
- N/ANCT00575211 · Study Looking at the Recovery of New Onset CardiomyopathyUniversity of Pittsburgh · completed · Cardiomyopathy · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- (1/2) Randomized Evaluation of Bromocriptine in Myocardial Recovery Therapy for Peripartum Cardiomyopathy (REBIRTH)UH3HL153847 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2022 to 2025 · $677,240 awarded in 2025Same name and institution; not confirmed by an ID
- (1/2) Randomized Evaluation of Bromocriptine in Myocardial Recovery Therapy for Peripartum Cardiomyopathy (REBIRTH)UG3HL153847 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2021 · $527,857 awarded in 2021Grant number is on one of their registry trials
- Genomic Analysis of Enhanced Response to Heart Failure Therapy in African AmericaR01MD009118 · NIMHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2014 to 2018 · $385,754 awarded in 2018Same name and institution; not confirmed by an ID
- Racial Genomic Differences and Heart Failure OutcomesK24HL069912 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2002 to 2013 · $161,032 awarded in 2013Same name and institution; not confirmed by an ID
- Immune Activation and Myocardial Recovery in Peripartum CardiomyopathyRC1HL102429 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2009 to 2010 · $499,818 awarded in 2010Same name and institution; not confirmed by an ID
- Genetic Modulation of Left Ventricular RecoveryR01HL075038 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2004 to 2008 · $352,012 awarded in 2008Same name and institution; not confirmed by an ID
- GENETIC ANALYSIS OF VERTEBRATE CARDIAC DEVELOPMENTK08HL002862 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 1993 to 1998 · $80,898 awarded in 1998Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:38 UTC. The ranking covers the 200 most relevant of 51 PubMed records, and a shared surname and initials can bring in a namesake. All 51 on PubMed
- Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy.Circulation · 2001374 citationsRCR 8.6
- Factors related to success and failure rates at 3-year follow-up in a multicenter study of overdentures supported by Brånemark implants.Int J Oral Maxillofac Implants · 1995160 citationsRCR 9.8
- Pharmacogenetic interactions between beta-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure.Circulation · 2001157 citationsRCR 3.4
- Randomized clinical trial of diathermy versus scalpel incision in elective midline laparotomy.Br J Surg · 200190 citationsRCR 3.8
- 89 citationsRCR 8.7
- Prosthodontic treatment, patient response, and the need for maintenance of complete implant-supported overdentures: an appraisal of 5 years of prospective study.Int J Prosthodont · 199788 citationsRCR 6.1
- Cardiopulmonary resuscitation feedback improves the quality of chest compression provided by hospital health care professionals.Am J Emerg Med · 201158 citationsRCR 2.5
- Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial.J Card Fail · 200957 citationsRCR 1.4
- Effect of statin therapy prior to elective percutaneous coronary intervention on frequency of periprocedural myocardial injury.Am J Cardiol · 200446 citationsRCR 1.0
- Effects of central and peripheral nicotinic blockade on human nicotine discrimination.Psychopharmacology (Berl) · 199940 citationsRCR 1.4